Enteran 30 mg/g

Hauptinformation

  • Handelsname:
  • Enteran 30 mg/g - Pulver zum Eingeben für Rinder und Schweine
  • Einheiten im Paket:
  • 4 x 10 g, Laufzeit: 60 Monate,10 x 10 g, Laufzeit: 60 Monate,500 g, Laufzeit: 60 Monate
  • Verwenden für:
  • Tiere
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Enteran 30 mg/g - Pulver zum Eingeben für Rinder und Schweine
    Österreich
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiebereich:
  • Antibiotics

Weitere Informationen

Status

  • Quelle:
  • AGES
  • Zulassungsnummer:
  • 8-00054
  • Letzte Änderung:
  • 07-11-2016

1-6-2018

Demulen 30 birth control pills: Packages containing broken or chipped pills

Demulen 30 birth control pills: Packages containing broken or chipped pills

Pfizer Canada Inc. has notified Health Canada that it has received complaints of broken or chipped pills involving Demulen 30, a prescription birth control pill. Health Canada has previously communicated on similar issues involving two other brands of birth control pills. Health Canada continues to remind women to check their packages of birth control pills and to report problems if they see them. If you notice anything unusual in the package, such as missing or damaged pills, you should return the packa...

Health Canada

31-5-2018

Onkologie

Onkologie

Das Ergebnisprotokoll der 30. Sitzung der Expertengruppe Off-Label - Fachbereich Onkologie – wurde veröffentlicht

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

30-5-2018

Enforcement Report for the Week of May 30, 2018

Enforcement Report for the Week of May 30, 2018

FDA - U.S. Food and Drug Administration

30-5-2018

Therios 75 ad us. vet., teilbare Kautabletten

Therios 75 ad us. vet., teilbare Kautabletten

● Die Neuzulassung erfolgte am 30.05.2018.

Institut für Veterinärpharmakologie und toxikologie

29-5-2018

Liste der Veröffentlichungen von Zusammenfassungen von Risikomanagement-plänen nach § 34 Abs. 1a AMG, Stand 30.04.2018

Liste der Veröffentlichungen von Zusammenfassungen von Risikomanagement-plänen nach § 34 Abs. 1a AMG, Stand 30.04.2018

Aktualisierte Liste der Veröffentlichungen von Zusammenfassungen von Risikomanagementplänen

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

19-4-2018

March 30, 2018: KC Paramedic Indicted for Stealing Fentanyl, Morphine from Ambulances

March 30, 2018: KC Paramedic Indicted for Stealing Fentanyl, Morphine from Ambulances

March 30, 2018: KC Paramedic Indicted for Stealing Fentanyl, Morphine from Ambulances

FDA - U.S. Food and Drug Administration

19-4-2018

March 30, 2018: Counterfeit Cigarette Smuggler Sentenced to Prison

March 30, 2018: Counterfeit Cigarette Smuggler Sentenced to Prison

March 30, 2018: Counterfeit Cigarette Smuggler Sentenced to Prison

FDA - U.S. Food and Drug Administration

19-4-2018

March 30, 2018: Lynn Man Sentenced to Over 10 Years in Prison for Role in Counterfeit Steroid Conspiracy

March 30, 2018: Lynn Man Sentenced to Over 10 Years in Prison for Role in Counterfeit Steroid Conspiracy

March 30, 2018: Lynn Man Sentenced to Over 10 Years in Prison for Role in Counterfeit Steroid Conspiracy

FDA - U.S. Food and Drug Administration

27-3-2018

Oribiotic ad us. vet., Salbe

Oribiotic ad us. vet., Salbe

● Die Zulassung wird am 30.09.2018 erlöschen.

Institut für Veterinärpharmakologie und toxikologie

2-11-2017

Beautiful Lose Weight Gold 30 Capsules

Beautiful Lose Weight Gold 30 Capsules

Safety Alert- Beautiful Lose Weight Gold 30 Capsules

Therapeutic Goods Administration - Australia

2-11-2017

Lose Weight 30 capsules

Lose Weight 30 capsules

Safety Alert- Lose Weight 30 capsules

Therapeutic Goods Administration - Australia

30-8-2017

Enforcement Report for the Week of August 30, 2017

Enforcement Report for the Week of August 30, 2017

FDA - U.S. Food and Drug Administration

30-11-2016

Enforcement Report for the Week of November 30, 2016

Enforcement Report for the Week of November 30, 2016

FDA - U.S. Food and Drug Administration

23-9-2016

The IMA will be closed from noon on Friday 30 September

The IMA will be closed from noon on Friday 30 September

The IMA will be closed from noon on Friday 30 September due to a staff meeting. If necessary call +354 899 6962.

IMA - Icelandic Medicines Agency

30-3-2016

Enforcement Report for the Week of March 30, 2016

Enforcement Report for the Week of March 30, 2016

FDA - U.S. Food and Drug Administration

30-12-2015

Enforcement Report for the Week of December 30, 2015

Enforcement Report for the Week of December 30, 2015

FDA - U.S. Food and Drug Administration

30-9-2015

Enforcement Report for the Week of September 30, 2015

Enforcement Report for the Week of September 30, 2015

FDA - U.S. Food and Drug Administration

30-7-2014

Enforcement Report for the Week of July 30, 2014

Enforcement Report for the Week of July 30, 2014

FDA - U.S. Food and Drug Administration

3-6-2014

Amendment of executive order on euphoriant substances 30 May 2014

Amendment of executive order on euphoriant substances 30 May 2014

On 30 May 2014, the substances below were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health.

Danish Medicines Agency

7-5-2014

Danish Pharmacovigilance Update  30 April 2014

Danish Pharmacovigilance Update 30 April 2014

In the April issue of Danish Pharmacovigilance Update:

Danish Medicines Agency

30-4-2014

Enforcement Report for the Week of April 30, 2014

Enforcement Report for the Week of April 30, 2014

FDA - U.S. Food and Drug Administration

30-10-2013

Enforcement Report for the Week of October 30, 2013

Enforcement Report for the Week of October 30, 2013

FDA - U.S. Food and Drug Administration

30-1-2013

Enforcement Report for the Week of January 30, 2013

Enforcement Report for the Week of January 30, 2013

FDA - U.S. Food and Drug Administration

31-5-2012

Enforcement Report for the Week of May 30, 2012

Enforcement Report for the Week of May 30, 2012

FDA - U.S. Food and Drug Administration

6-6-2018

Electronic Submissions Update – Reminder that the transition period for current Australian regional specification ends 30 June 2018

Electronic Submissions Update – Reminder that the transition period for current Australian regional specification ends 30 June 2018

Electronic submission update - version 3.1 specifications reminder

Therapeutic Goods Administration - Australia

30-5-2018

The FDA will accept submissions from June 1, 2018, through Sept. 30, 2018, and intends to announce the selected applicants in November 2018.  #FDAInnovationChallenge

The FDA will accept submissions from June 1, 2018, through Sept. 30, 2018, and intends to announce the selected applicants in November 2018. #FDAInnovationChallenge

The FDA will accept submissions from June 1, 2018, through Sept. 30, 2018, and intends to announce the selected applicants in November 2018. #FDAInnovationChallenge

FDA - U.S. Food and Drug Administration

30-5-2018

AUBAGIO (Sanofi-Aventis groupe)

AUBAGIO (Sanofi-Aventis groupe)

AUBAGIO (Active substance: Teriflunomide) - Centralised - Renewal - Commission Decision (2018)3467 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2514/R/16

Europe -DG Health and Food Safety

30-5-2018

Descovy (Gilead Sciences Ireland UC)

Descovy (Gilead Sciences Ireland UC)

Descovy (Active substance: emtricitabine / tenofovir alafenamide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3471 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4094/T/30

Europe -DG Health and Food Safety

30-5-2018

Plavix (Sanofi Clir SNC)

Plavix (Sanofi Clir SNC)

Plavix (Active substance: Clopidogrel) - Centralised - Yearly update - Commission Decision (2018)3470 of Wed, 30 May 2018

Europe -DG Health and Food Safety

30-5-2018

Atosiban SUN (Sun Pharmaceutical Industries Europe BV)

Atosiban SUN (Sun Pharmaceutical Industries Europe BV)

Atosiban SUN (Active substance: atosiban) - Centralised - Renewal - Commission Decision (2018)3469 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2329/R/12

Europe -DG Health and Food Safety

30-5-2018

Lixiana (Daiichi Sankyo Europe GmbH)

Lixiana (Daiichi Sankyo Europe GmbH)

Lixiana (Active substance: edoxaban) - Centralised - Yearly update - Commission Decision (2018)3465 of Wed, 30 May 2018

Europe -DG Health and Food Safety

30-5-2018

Eviplera (Gilead Sciences Ireland UC)

Eviplera (Gilead Sciences Ireland UC)

Eviplera (Active substance: emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3453 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2312/T/91

Europe -DG Health and Food Safety

30-5-2018

Vemlidy (Gilead Sciences Ireland UC)

Vemlidy (Gilead Sciences Ireland UC)

Vemlidy (Active substance: tenofovir alafenamide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3449 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4169/T/13

Europe -DG Health and Food Safety

30-5-2018

Tecfidera (Biogen Idec Limited)

Tecfidera (Biogen Idec Limited)

Tecfidera (Active substance: Dimethyl fumarate) - Centralised - Yearly update - Commission Decision (2018)3458 of Wed, 30 May 2018

Europe -DG Health and Food Safety

30-5-2018

Ledaga (Actelion Registration Ltd)

Ledaga (Actelion Registration Ltd)

Ledaga (Active substance: chlormethine) - Centralised - Yearly update - Commission Decision (2018)3456 of Wed, 30 May 2018

Europe -DG Health and Food Safety

30-5-2018

Hepsera (Gilead Sciences Ireland UC)

Hepsera (Gilead Sciences Ireland UC)

Hepsera (Active substance: adefovir dipivoxil) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3450 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/485/T/78

Europe -DG Health and Food Safety

30-5-2018

Epclusa (Gilead Sciences Ireland UC)

Epclusa (Gilead Sciences Ireland UC)

Epclusa (Active substance: sofosbuvir/velpatasvir) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3452 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4210/T/27

Europe -DG Health and Food Safety

30-5-2018

Temodal (Merck Sharp and Dohme Limited)

Temodal (Merck Sharp and Dohme Limited)

Temodal (Active substance: temozolomide) - PSUSA - Modification - Commission Decision (2018)3466 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/229/PSUSA/2886/201707

Europe -DG Health and Food Safety

30-5-2018

Sevohale (Chanelle Pharmaceuticals Manufacturing Limited)

Sevohale (Chanelle Pharmaceuticals Manufacturing Limited)

Sevohale (Active substance: sevoflurane) - Centralised - 2-Monthly update - Commission Decision (2018)3407 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4199/IB/3

Europe -DG Health and Food Safety

30-5-2018

Vokanamet (Janssen-Cilag International NV)

Vokanamet (Janssen-Cilag International NV)

Vokanamet (Active substance: canagliflozin / metformin hydrochloride) - Centralised - Yearly update - Commission Decision (2018)3463 of Wed, 30 May 2018

Europe -DG Health and Food Safety

30-5-2018

Senshio (Shionogi Limited)

Senshio (Shionogi Limited)

Senshio (Active substance: ospemifene) - PSUSA - Modification - Commission Decision (2018)3462 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10340/201708

Europe -DG Health and Food Safety

30-5-2018

Bortezomib Accord (Accord Healthcare Limited)

Bortezomib Accord (Accord Healthcare Limited)

Bortezomib Accord (Active substance: bortezomib) - Centralised - Variation - Commission Decision (2018)3460 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3984/X/8

Europe -DG Health and Food Safety

28-5-2018

 Minutes of the HMPC 29-30 January 2018 meeting

Minutes of the HMPC 29-30 January 2018 meeting

Europe - EMA - European Medicines Agency

24-5-2018

Inaugural Industry Forum on Good Manufacturing Practice (GMP)

Inaugural Industry Forum on Good Manufacturing Practice (GMP)

Registrations for the 2018 GMP Forum closing on Wednesday 30 May 2018

Therapeutic Goods Administration - Australia

18-5-2018

Odefsey (Gilead Sciences Ireland UC)

Odefsey (Gilead Sciences Ireland UC)

Odefsey (Active substance: emtricitabine / rilpivirine / tenofovir alafenamide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3152 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4156/T/30

Europe -DG Health and Food Safety

18-5-2018

News and press releases:  European Medicines Agency closed 21 May 2018

News and press releases: European Medicines Agency closed 21 May 2018

EMA closed from 18:30 on Friday 18 May until 7:30 on Tuesday 22 May 2018

Europe - EMA - European Medicines Agency

15-5-2018

Tafinlar (Novartis Europharm Limited)

Tafinlar (Novartis Europharm Limited)

Tafinlar (Active substance: DABRAFENIB) - Centralised - Renewal - Commission Decision (2018)3010 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2604/R/30

Europe -DG Health and Food Safety

7-5-2018

News and press releases:  European Medicines Agency closed 9-11 May 2018

News and press releases: European Medicines Agency closed 9-11 May 2018

EMA closed from 18:30 on Tuesday 8 May until 7:30 on Monday 14 May 2018

Europe - EMA - European Medicines Agency

30-4-2018

CERTIFECT (Merial)

CERTIFECT (Merial)

CERTIFECT (Active substance: (S)-Methoprene, Fipronil, Amitraz) - Withdrawal - Commission Decision (2018)2687 of Mon, 30 Apr 2018

Europe -DG Health and Food Safety